Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases
- PMID: 15858854
- DOI: 10.1002/jps.20322
Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases
Erratum in
- J Pharm Sci. 2007 Nov;96(11):3151-2
Abstract
Tissue-to-plasma water partition coefficients (Kpu's) form an integral part of whole body physiologically based pharmacokinetic (WBPBPK) models. This research aims to improve the predictability of Kpu values for moderate-to-strong bases (pK(a) > or = 7), by developing a mechanistic equation that accommodates the unique electrostatic interactions of such drugs with tissue acidic phospholipids, where the affinity of this interaction is readily estimated from drug blood cell binding data. Additional model constituents are drug partitioning into neutral lipids and neutral phospholipids, and drug dissolution in tissue water. Major assumptions of this equation are that electrostatic interactions predominate, drugs distribute passively, and non-saturating conditions prevail. Resultant Kpu predictions for 28 moderate-to-strong bases were significantly more accurate than published equations with 89%, compared to 45%, of the predictions being within a factor of three of experimental values in rat adipose, bone, gut, heart, kidney, liver, muscle, pancreas, skin, spleen and thymus. Predictions in rat brain and lung were less accurate probably due to the involvement of additional processes not incorporated within the equation. This overall improvement in prediction should facilitate the further application of WBPBPK modeling, where time, cost and labor requirements associated with experimentally determining Kpu's have, to a large extent, deterred its application.
(c) 2005 Wiley-Liss, Inc. and
Similar articles
-
Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.J Pharm Sci. 2006 Jun;95(6):1238-57. doi: 10.1002/jps.20502. J Pharm Sci. 2006. PMID: 16639716
-
A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.J Pharm Sci. 2000 Jan;89(1):16-35. doi: 10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E. J Pharm Sci. 2000. PMID: 10664535
-
Incorporation of lysosomal sequestration in the mechanistic model for prediction of tissue distribution of basic drugs.Eur J Pharm Sci. 2017 Nov 15;109:419-430. doi: 10.1016/j.ejps.2017.08.014. Epub 2017 Aug 18. Eur J Pharm Sci. 2017. PMID: 28823852
-
On the Nature of Physiologically-Based Pharmacokinetic Models -A Priori or A Posteriori? Mechanistic or Empirical?Pharm Res. 2017 Mar;34(3):529-534. doi: 10.1007/s11095-016-2089-8. Epub 2016 Dec 27. Pharm Res. 2017. PMID: 28028770 Free PMC article. Review.
-
Prediction of the volume of distribution of a drug: which tissue-plasma partition coefficients are needed?J Pharm Pharmacol. 2002 Sep;54(9):1237-45. doi: 10.1211/002235702320402080. J Pharm Pharmacol. 2002. PMID: 12356278 Review.
Cited by
-
Mechanistic modeling to predict the transporter- and enzyme-mediated drug-drug interactions of repaglinide.Pharm Res. 2013 Apr;30(4):1188-99. doi: 10.1007/s11095-012-0956-5. Epub 2013 Jan 10. Pharm Res. 2013. PMID: 23307347
-
Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.Integr Biol (Camb). 2015 Apr;7(4):383-91. doi: 10.1039/c4ib00292j. Integr Biol (Camb). 2015. PMID: 25739725 Free PMC article. Review.
-
Predictive Performance of Physiologically Based Pharmacokinetic and Population Pharmacokinetic Modeling of Renally Cleared Drugs in Children.CPT Pharmacometrics Syst Pharmacol. 2016 Sep;5(9):475-83. doi: 10.1002/psp4.12101. Epub 2016 Aug 27. CPT Pharmacometrics Syst Pharmacol. 2016. PMID: 27566992 Free PMC article.
-
Lumping of physiologically-based pharmacokinetic models and a mechanistic derivation of classical compartmental models.J Pharmacokinet Pharmacodyn. 2010 Aug;37(4):365-405. doi: 10.1007/s10928-010-9165-1. Epub 2010 Jul 27. J Pharmacokinet Pharmacodyn. 2010. PMID: 20661651
-
Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies).Pharmaceutics. 2022 May 30;14(6):1163. doi: 10.3390/pharmaceutics14061163. Pharmaceutics. 2022. PMID: 35745735 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources